|
|
|||
| |||||||||||||||||||||||||||||||||
The importance of pathology and immunology in transplantation is increasing with the widespread use of organ and tissue transplantation for the treatment of end-stage diseases. Recently, the end points for clinical trials in organ transplantation have been based on pathology, not graft failure. Many immunosuppressive drugs in development are based on molecules in the immune system itself. There is a need for material that makes this fast-moving area of science accessible to students, trainees, and physicians in practice. Pathology and Immunology of Transplantation and Rejection provides an overview of many areas of the field to which a number of
HOME | SUBSCRIBE | SEARCH | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | PRIVACY | TERMS OF USE | HELP | beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved. |